Icon (ICLR) Restructuring Costs (2011 - 2026)
Icon's (ICLR) quarterly Restructuring Costs came in at $20.9 million in Q2 2026, down 51.33% year-over-year from $42.9 million in Q2 2025, and up 107.46% quarter-over-quarter from $10.1 million in Q1 2026.
Analysis
Icon (ICLR) Restructuring Costs (2011 - 2026) Analysis & Trends
Icon (ICLR) has reported Restructuring Costs for 14 consecutive years, with $20.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Restructuring Costs fell 51.33% year-over-year to $20.9 million in Q2 2026; TTM through Jun 2026 was $27.8 million, a 78.42% decrease from a year earlier, with the FY2025 full-year figure at $79.1 million, down 14.17% from the prior year.
- Restructuring Costs was $20.9 million for Q2 2026 at Icon, up from $10.1 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $46.3 million in Q4 2024 and troughed at -$3.2 million in Q4 2025.
- A 5-year average of $20.6 million and a median of $15.5 million in 2026 frame the typical range for Restructuring Costs.
- Across the five-year window, Restructuring Costs tumbled 107.0% in 2022 and jumped 652.95% in 2023, its largest moves.
- Over 5 years, Restructuring Costs stood at -$1.7 million in 2022, then jumped by 652.95% to $9.7 million in 2023, then jumped by 379.65% to $46.3 million in 2024, then slumped by 106.96% to -$3.2 million in 2025, then jumped by 747.78% to $20.9 million in 2026.
- The last three Restructuring Costs figures came in at $20.9 million (Q2 2026), $10.1 million (Q1 2026), and -$3.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.90 Mn |
| Mar 31, 2026 | 10.08 Mn |
| Dec 31, 2025 | -3.23 Mn |
| Jun 30, 2025 | 42.95 Mn |
| Mar 31, 2025 | 39.35 Mn |
| Dec 31, 2024 | 46.33 Mn |
| Jun 30, 2024 | 45.79 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Jun 30, 2023 | 35.66 Mn |
| Mar 31, 2023 | 9.73 Mn |
| Dec 31, 2022 | -1.75 Mn |
| Sep 30, 2022 | 6.20 Mn |
| Jun 30, 2022 | 22.49 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 24.94 Mn |
| Sep 30, 2021 | 6.16 Mn |
| Jun 30, 2021 | 20.02 Mn |
| Mar 31, 2021 | 12.50 Mn |
| Dec 31, 2020 | -262,000.00 |
| Sep 30, 2020 | 402,000.00 |